（文章来源：每日经济新闻） 每经AI快讯，11月25日，广济药业涨停走出2连板，2天累计涨幅达20.93%。 ...

Core Insights - The Hubei state-owned enterprise reform sector saw a rise of 0.58% on November 24, with Guangji Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] Stock Performance Summary - Guangji Pharmaceutical (000952) closed at 7.83, with a gain of 9.97% and a trading volume of 66,800 shares, amounting to a transaction value of 50.81 million yuan [1] - Santer Cableway (002159) closed at 15.45, up 2.66%, with a trading volume of 31,200 shares and a transaction value of 47.85 million yuan [1] - LIGONG Optical Science (300557) closed at 27.78, up 2.58%, with a trading volume of 24,400 shares and a transaction value of 67.45 million yuan [1] - Xianglong Electric (600769) closed at 12.90, up 2.54%, with a trading volume of 75,400 shares and a transaction value of 96.24 million yuan [1] - Hubei Broadcasting (000665) closed at 5.97, up 1.88%, with a trading volume of 400,200 shares and a transaction value of 237 million yuan [1] Capital Flow Analysis - The Hubei state-owned enterprise reform sector experienced a net outflow of 303 million yuan from main funds, while retail investors saw a net inflow of 300 million yuan [2] - The main funds showed a significant net inflow in Guangji Pharmaceutical, amounting to 19.41 million yuan, while retail investors had a net outflow of 11.25 million yuan [3] - Hubei Energy (000883) had a net inflow of 16.12 million yuan from main funds, but a net outflow of 20.48 million yuan from retail investors [3]

业绩方面，2025年1月-9月，广济药业实现营业收入4.29亿元，同比减少7.12%；归属净利润-9729.86万 元，同比增长38.64%。 异动原因 来源：市场资讯 涉及维生素B2概念，为全球主要维生素B2产品供应商；涉及流感概念，其生产的小儿氨酚黄那敏颗粒 可缓解儿童普通感冒及流行性感冒引发的发热、头痛等相关症状；具有国企背景，控股股东为长江产业 投资集团，最终控制人为湖北省国资委。 11月24日，广济药业收盘首板涨停，沪深京交易所数据显示，截至当日收盘，广济药业报7.83元/股，成 交额5081.14万元，总市值27.15亿元，封板资金3001.8万元。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 ...

AI and Technology - Google has released a new image model, attracting attention in the AI sector [2] - 360, a leader in AI search, has developed the 360 Smart Brain with ten core capabilities and hundreds of detailed functions, reporting a net loss of 120 million in Q3, narrowing from mid-year losses [2] - Jiuxi Software has launched its new generation large model application management platform, Nvwa GPT, which integrates and provides capabilities for large model management and intelligent orchestration [2] Aerospace and Defense - Japan has announced the deployment of missiles in sensitive areas, impacting defense-related companies [2] - Aerospace Power, a subsidiary of the Aerospace Science and Technology Group, has seen stock performance with a recent increase [2] - China Shipbuilding Industry Group, which controls multiple defense-related companies, is the only military ship production base in South China [2] E-commerce and Retail - Alibaba's "Qianwen" app has surpassed 10 million downloads in its first week of public testing [3] - Sanjiang Shopping, the largest local supermarket chain in Zhejiang, has Alibaba as its second-largest shareholder and is involved in the sale of prepared dishes [3] - DataPort, a leading data center company, provides infrastructure solutions and serves major internet companies like Alibaba, Tencent, Baidu, and NetEase [3] Real Estate - Multiple regions have issued notifications to promote the stable and healthy development of the real estate market [5] - Everbright Jiabao, a real estate development company under Everbright Group, focuses on non-performing asset management in Zhejiang [5] Automotive - GAC Group has officially launched its all-solid-state battery pilot production line [5] - Jinlong Automobile, a major bus manufacturer, has partnered with Baidu to produce China's first commercial-grade autonomous micro-circulation vehicle [5] Renewable Energy - Guosheng Technology, a top global manufacturer of heterojunction products, is focusing on high-efficiency solar cells and has plans for a solid-state battery project [6] - Hemei Group's subsidiary is investing in a green hydrogen project with an estimated total investment of around 700 million [6] Food and Beverage - Xinhua Du, a leading e-commerce platform for liquor, has seen stock performance with a recent increase [4] - Hasi Lian, a beauty brand, is focusing on skincare products and has developed a series of medical-grade dressings [5]

Group 1 - The vitamin sector experienced a strong upward movement at the beginning of trading on November 24, with notable gains in several companies [2] - Harbin Sanlian reached the daily limit increase, while Jinshi Yao surged over 7% and Guangji Pharmaceutical rose more than 6% [2] - Other companies such as Shuoshi Biological, Meinong Biological, and Hendi Pharmaceutical also saw increases in their stock prices [2]

Core Viewpoint - On November 21, a total of 10 listed companies will have their restricted shares unlocked, with a total market value of approximately 737 million yuan [1] Summary by Category Restricted Share Unlocking Details - The companies and their respective restricted share unlocking details are as follows: - Ice Wheel Environment (Stock Code: 000811) - 220,000 shares from equity incentive [1] - Guangji Pharmaceutical (Stock Code: 000952) - 437,400 shares from equity incentive [1] - Nanjing Pharmaceutical (Stock Code: 600713) - 493,000 shares from equity incentive [1] - Rhine Biology (Stock Code: 002166) - 3,371,500 shares from equity incentive [1] - Dawei Co., Ltd. (Stock Code: 002213) - 83,900 shares from equity incentive [1] - Anke Bio (Stock Code: 300009) - 1,784,400 shares from equity incentive [1] - Qingxin Environment (Stock Code: 002573) - 828,000 shares from equity incentive [1] - Junhe Co., Ltd. (Stock Code: 603617) - 2,490,000 shares from equity incentive [1] - Jingquan Hua (Stock Code: 002885) - 230,100 shares from equity incentive [1] - Matrix Co., Ltd. (Stock Code: 301365) - 55,032,400 shares from pre-issue restrictions [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 湖北广济药业股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 董事会 湖北广济药业股份有限公司（以下简称"公司"）董事会于2025年11月20日收到独立董事郭炜先生的书面 辞职报告，郭炜先生因个人原因申请辞去公司第十一届董事会独立董事职务，同时辞去审计委员会主任 委员、薪酬与考核委员会委员、预算管理委员会委员职务。辞职后，郭炜先生将不再担任公司任何职 务。 2025年11月20日 郭炜先生的辞职将导致公司独立董事人数少于董事会成员的三分之一，且独立董事中缺少会计专业人 士。根据《中华人民共和国公司法》《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》 以及《公司章程》等相关规定，郭炜先生的辞职报告自公司股东会选举出新任独立董事后方可生效。在 公司召开股东会选举产生新任独立董事前，郭炜先生将继续履行独立董事及董事会专门委员会委员的职 责。郭炜先生辞职不会对公司治理和生产经营带来重大影响，公司将按照规定尽快完成新任独立董事及 董事会相关专门委员会委员的选举工作。 截至本公告披露日，郭炜先生未持有 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000952 证券简称：广济药业（维权） 公告编号：2025-058 湖北广济药业股份有限公司 郭炜先生在担任公司独立董事期间，恪尽职守、客观独立，在促进公司规范运作等方面发挥了积极有效 的作用，公司董事会对郭炜先生在任职期间为公司发展做出的贡献表示衷心感谢！ 特此公告。 2025年11月20日 关于独立董事辞职的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 湖北广济药业股份有限公司（以下简称"公司"）董事会于2025年11月20日收到独立董事郭炜先生的书面 辞职报告，郭炜先生因个人原因申请辞去公司第十一届董事会独立董事职务，同时辞去审计委员会主任 委员、薪酬与考核委员会委员、预算管理委员会委员职务。辞职后，郭炜先生将不再担任公司任何职 务。 郭炜先生的辞职将导致公司独立董事人数少于董事会成员的三分之一，且独立董事中缺少会计专业人 士。根据《中华人民共和国公司法》《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》 以及《公司章程》等相关规定，郭炜先生的辞职报告自公司股东会选举出新任独立 ...

（编辑 楚丽君） 证券日报网讯 11月20日晚间，广济药业发布公告称，公司董事会于2025年11月20日收到独立董事郭炜 先生的书面辞职报告，郭炜先生因个人原因申请辞去公司第十一届董事会独立董事职务，同时辞去审计 委员会主任委员、薪酬与考核委员会委员、预算管理委员会委员职务。 ...

（文章来源：证券日报） 证券日报网讯广济药业11月20日在互动平台回答投资者提问时表示，公司按照相关规定在定期报告披露 相应时点的股东人数情况，敬请关注公司定期报告。 ...